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Background/purpose Caustic esophageal strictures still
represent a catastrophic problem in children of our country.
Management protocol is usually started by regular
esophageal dilatation in which multiple sessions may be
needed until the resolution of dysphagia; however, in many
cases endoscopic dilatation fails and therefore esophageal
replacement is eventually required. Our aim is to assess
the role of mitomycin C application in the management
of caustic esophageal stricture refractory to regular
endoscopic dilatation.
Patients and methods Patients with resistant caustic
esophageal stricture were subjected to topical mitomycin C
application on stricture site after endoscopic dilatation.
Patients were followed up clinically using validated
dysphagia score to assess the improvement of dysphagia,
radiologically by contrast esophagogram and
endoscopically to confirm resolution of the stricture.
Results were analyzed and compared with results of a
control group managed at the institution by a regular
dilatation protocol.
Results During the period January 2008 to June 2010,
12 patients with resistant caustic esophageal stricture
were followed at our unit of whom six had a short
esophageal stricture (< 3 cm) and six had a long stricture
( > 3 cm). Topical mitomycin C application resulted in
clinical and radiological resolution of dysphagia and
strictures in 83% and 66% respectively, compared with
44 (eight out of 18 patients with short stricture) and
25% (two out of eight patients with long stricture) in
the control group.
Conclusion Mitomycin C application can markedly
improve the outcome of patients with caustic esophageal
stricture, reducing the number of required sessions for
endoscopic dilatation. However, double-blinded
randomized controlled trial is needed to prove its
effectiveness. Ann Pediatr Surg 7:49–54 c 2011
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Introduction
Although the incidence of caustic esophageal strictures has
declined in developed countries because of improvement
in product packaging and health education, many children
in developing countries continue to sustain caustic
esophageal injuries from accidental ingestion of alkaline
or acidic products, resulting in coagulative or liquifactive
necrosis of varied length and depth of the esophagus [1,2].
These esophageal injuries eventually lead to stricture
formation in approximately 6 weeks. These strictures
require repeated esophageal dilatations, or in severe cases,
esophageal replacement. Although a number of agents have
been tried experimentally to prevent stricture formation,
few have gained clinical application [3].
Mitomycin C (MMC) is an antineoplastic agent that
inhibits fibroblast proliferation and reduces collagen
cross-linking, which has been proven to be effective in
reducing scar formation in animal experiments [2]. In
rats, MMC proved to be effective in preventing strictures
following experimental caustic esophageal injury, in a
dose-dependent manner [3].
MMC has been used successfully with no complications
as an adjuvant treatment in several ophthalmological
procedures and in laryngotracheal stenosis [4]. Topical
application of MMC after dilatation is a new technique
that has been recently used for management of esopha-
geal stricture in children, and a few case reports were
published; however, no planned studies have been
reported yet [2,4–8].
The purpose of this study was to evaluate the effect of
MMC topical application after dilatation of caustic
esophageal stricture resistant on regular endoscopic
dilatation.
Patients and methods
Children presented to the pediatric surgery department,
Ain Shams University, with resistant caustic esophageal
strictures (who failed to improve after at least 6 months
of regular endoscopic esophageal dilatation) were in-
cluded in this study. Patients with previous esophageal
surgery and patients known to have hypersensitivity
or contraindication for MMC were excluded from the
study.
A detailed history was taken, including time and type of
corrosive ingestion, duration and number of previous
sessions of endoscopic dilatation, and the degree
of dysphagia before and after the previous dilatation
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period. Degree of dysphagia was evaluated according to
a validated dysphagia scoring system [9] (Table 1), and
a new barium swallow study was conducted before
application of MMC.
Informed consent was taken from the parents after an
explanation of the endoscopic technique and the possible
associated complications including iatrogenic perforation
and failure.
MMC solution (Mitomycin C Kyowa, Biochem Pharma-
ceutical Industries Ltd, India) was prepared by diluting
10 mg of its commercial powder form in 25 ml of distilled
water to reach a concentration of 0.4 mg/ml, to be applied
on the stricture site for 5 min estimated using a stopwatch.
Technique
Our technique starts by esophageal dilatation using
flexible endoscopy and a wire-guided Savary Gilliard
dilator under the fluoroscopy. The size of the child’s
thumb was considered as a rough measure of esophageal
lumen and for the appropriate size of the dilator used.
After the dilatation, we accurately assessed the stricture
site and length by visualizing it endoscopically. Then,
application of MMC was followed using a rigid esophago-
scope with a piece of cotton soaked in diluted MMC
solution that was delivered to the stricture site by a
grasper. The soaked cotton piece was kept applied on the
esophageal wall at stricture site for 5 minutes. Postendo-
scopy chest radiograph was a must for exclusion of
iatrogenic esophageal perforation.
Follow-up
Patients were followed monthly by the dysphagia score
(DS), by the barium swallow study 3 and 6 months after
MMC application, and endoscopically 1-month after the
session of MMC application for assessment of integrity and
continuity of esophageal mucosa over the stricture site.
Our primary endpoint was the number of dilatations
required to make the child free of dysphagia.
The results were compared with a control group of
patients with caustic esophageal stricture, managed at
the same institute in the previous 2 years, who were on a
regular dilatation protocol.
Results
From the period January 2008 to June 2010, 12 patients
were followed at our unit with resistant caustic esopha-
geal stricture of whom seven were boys and five were
girls. Their age at presentation was ranging from 1.75 to
4.5 years (mean: 2.8 years), and all injuries were caused
by alkali corrosive ingestion, except one, which was
caused by ingestion of an acidic product. Six of them had
a short esophageal stricture (< 3 cm in length) and the
other six had a long stricture (> 3 cm in length). These
patients underwent multiple sessions of regular endo-
scopic dilatation with no improvement of their dysphagia;
they underwent a mean number of 9.3 dilatation sessions
(ranging from 6 to 18 times) within a mean period of 9.5
months (ranging from 6 to 24 months).
All 12 patients were subjected to topical MMC applica-
tion after dilatation, once for the short strictures and in
multiple sessions for the long ones. Patients were
followed for a period ranging from 6 to 28 months (mean:
13.6 months).
In the control regular dilatation group, we had 26 patients
of which 17 were boys and nine were girls, with age
ranging from 1.5 to 5 years (mean: 2.9 years). All had
alkali-induced strictures. Eighteen of them had a short
stricture, whereas the other eight had a long one.
Table 1 Dysphagia score (Knyrim et al. [9])
Dysphagia score
0 Able to eat normal diet/no dysphagia
1 Able to swallow some solid foods
2 Able to swallow only semisolid foods
3 Able to swallow only liquids
4 Unable to swallow anything/total dysphagia
Fig. 1
Esophagogram before mitomycin C application for a patient with
resistant localized esophageal stricture, dysphagia score = 2.
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Patients with short stricture and who had MMC
application needed an average of 2.3 dilatation sessions
(three patients needed one session, two patients needed
two sessions, and the sixth nonresponding patient needed
seven sessions till date) to obtain five out of six patients
who were completely free of dysphagia, reaching DS = 0
(Figs 1 and 2), whereas the sixth patient had only partial
improvement with DS = 1. In contrast, in the regular
dilatation group, we needed an average of 8.3 dilatation
sessions (ranging from five to 12 sessions) to obtain only
eight out of 18 patients who were completely free of
dysphagia (Fig. 3).
Patients with long stricture and who had MMC applica-
tion needed an average of 5.5 dilatation sessions (ranging
from four to 11 sessions) to obtain four out of six patients
Fig. 2
Markedly improved esophagogram of the same patient after mitomycin


















The success rate of both MMC group and 
regular dilatations group in short strictures
Still Symptomatic
Resolved 
The success rate of both mitomycin C (MMC) group and regular
dilatations group in short strictures.
Fig. 4
Esophagogram before mitomycin C application for a patient with 6-cm
esophageal stricture, dysphagia score = 2.
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who were completely free of dysphagia, reaching DS = 0
(Figs 4 and 5), whereas the fifth patient had only partial
improvement (from DS = 2 to DS = 1) and the sixth one
had not improved at all (DS = 2). In contrast, in the
regular dilatation group, we needed an average of 11.5
dilatation sessions (ranging from nine to 15 sessions) to
obtain only two out of eight patients who were completely
free of dysphagia, with no improvement in the rest of the
cases (Fig. 6).
It is to be noted that long strictures needed multiple
sessions of MMC application; in our patients, we applied
it two to five times (mean: 3.8 times) for stricture length
ranging from 4 to 7 cm (mean: 5.3 cm).
It is worthy to be mentioned that follow-up endoscopy
after MMC application showed healthy esophageal
mucosa over the stricture site. No intraoperative or
postoperative complications were encountered in both
groups of patients (Table 2).
Discussion
The ideal management of caustic esophageal stricture
still represents a great challenge for pediatric surgeons.
Serial endoscopic dilatations and esophageal replace-
ment have been used with varying levels of success
[1,10]. Esophageal salvage is preferable when possible,
but repeated sessions of dilatation may be required because
of occurrence of restenosis. The cause of recurrent stricture
is unknown, but intense fibrogenesis during healing and
after the traumatic dilatation procedure may be the cause,
making repeated dilatations necessary, but with an
increased risk of complications and perforation [11,12].
In our institution, failure of dilatation of long, multiple,
and persistent strictures was an indication of esophageal
replacement. The drawbacks of repeated dilatation
include psychological problems, withdrawal from school,
hospital fears, and familial problems [1,13]. Trials to
decrease the number of dilatations, to avoid surgery, and
to revert strictures included the use of steroid injection in
localized strictures, which increased the intervals be-
tween dilatation but did not decrease the need for
replacement [1], stents with its high incidence of failure
and morbidity [5], and many other inapplicable experi-
mental studies [3,14,15]. Sporadic trials using MMC
application on localized strictures have shown better
outcome with less number of dilatations [2,5,7,8]. A pilot
study conducted at our institute showed marked
improvement of the dysphagia with a decrease in the
number of dilatations and in the number of replacements.
MMC has an antiproliferative effect on fibroblasts. By
bonding to DNA, it inhibits DNA-dependent RNA
synthesis and reduces fibroblastic proliferation and
Fig. 5
Markedly improved esophagogram of the same patient after MMC


















The success rate of both MMC group and 
regular dilatations group in long strictures
Still Symptomatic
Resolved 
The success rate of both mitomycin C (MMC) group and regular
dilatations group in long strictures.
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collagen bonding [16]. The healthy mucosa that was
observed endoscopically after the application of MMC
suggested that MMC, by reducing the fibrogenesis
process in submucosa, gives the mucosa enough time to
creep and to cover the stricture site, which prevents
restenosis again; however, biopsy for histopathological
examination is required to prove this effect.
No data exist that indicate the most effective concentra-
tion, duration, or frequency of application of MMC. We
used a solution of 0.4 mg/ml MMC and applied it to the
stricture site for 5 min. Other investigators reported
usage of 1 mg/ml concentration to be applied for 2 min on
a small number of patients with no related complications
[5,16]. However, double-blinded randomized trial is
needed to justify which concentration and duration is
more effective and safer.
In this study, we had six patients with a short esophageal
stricture, this group had an excellent response to MMC
application with a success rate of 83%. The responding
five patients needed only one or two sessions of dilatation
and now they are able to eat solid food freely with
medium-term follow-up of 6–28 months till date. This
represents a much better outcome than that achieved by
the other groups of regular dilatation with a lower success
rate of 44%, in addition to the need for more numbers of
dilatations. Our results were consistent with the other
published case reports where they stated the marked
response of resistant esophageal stricture, either caustic
or anastomotic site strictures, to MMC application
[2,5,7,8]. Kumar and Bhatnagar [7] reported a 90%
success rate of MMC application on 10 patients with
esophageal stricture, of which six of them had post-
anastomotic stricture and the other four were fresh
caustic stricture cases; these patients needed a mean
number of 3.4 dilatations.
In the literature, there is no reported trial of MMC
application or any other local chemical substance on long
caustic esophageal stricture, and no available accurate
data about the success rate of regular dilatation on long
esophageal stricture, but it is reported that most of them
eventually end by esophageal replacement [1]. In our
study, the six patients with long esophageal stricture who
were subjected to multiple sessions of MMC application
obtained a success rate of 66.6% compared with only 25%
in the regular dilatation group. The stricture length of
5–6 cm in four patients showed good response to MMC
multiple (two–five times) application sessions; these
patients can now eat everything with no need for more
sessions of dilatation or surgical intervention for 6–23
months of follow-up till date.
Although the success rate of MMC application in long
stricture is less than being achieved in short ones with
the need for multiple applications, it is worthy to be tried
before the decision of esophageal replacement is taken in
these patients because, to date, there is no better
substitute for the native esophagus; the ideal graft does
not exist [1].
Conclusion
MMC topical application can markedly improve the
outcome of patients with caustic esophageal stricture,
reducing the number of required sessions for endoscopic
dilatation. It should be considered as an adjunct new
modality and a potential alternative to repeated dilata-
tions, stent placement, or surgery for the management
of resistant caustic esophageal strictures, either short or
long.
However, prospective double-blinded randomized con-
trolled trial with long-term assessment of outcomes is
required to prove the efficacy of MMC in these patients.
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